Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 761

1.

Point Shear Wave Elastography by Acoustic Radiation Force Impulse Quantification in Comparison to Transient Elastography for the Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C: A Prospective International Multicenter Study.

Friedrich-Rust M, Lupsor M, de Knegt R, Dries V, Buggisch P, Gebel M, Maier B, Herrmann E, Sagir A, Zachoval R, Shi Y, Schneider MD, Badea R, Rifai K, Poynard T, Zeuzem S, Sarrazin C.

Ultraschall Med. 2015 May 13. [Epub ahead of print]

PMID:
25970201
2.

Endoscopic findings in patients with eosinophilic esophagitis.

Waidmann O, Finkelmeier F, Welker MW, Sprinzl K, Zeuzem S, Albert JG.

Z Gastroenterol. 2015 May;53(5):379-384. Epub 2015 May 12.

PMID:
25965984
3.

Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hcv genotype 1 infection: Analysis of phase 3 ION trials.

Alqahtani SA, Afdhal N, Zeuzem S, Gordon S, Mangia A, Kwo P, Fried M, Yang JC, Ding X, Pang PS, McHutchison JG, Pound D, Reddy KR, Marcellin P, Kowdley KV, Sulkowski M.

Hepatology. 2015 May 11. doi: 10.1002/hep.27890. [Epub ahead of print]

PMID:
25963890
4.

Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients - authors' reply.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O.

Aliment Pharmacol Ther. 2015 Jun;41(11):1225. doi: 10.1111/apt.13207. No abstract available.

PMID:
25939474
5.

From non-A, non-B hepatitis to hepatitis C virus cure.

Pawlotsky JM, Feld JJ, Zeuzem S, Hoofnagle JH.

J Hepatol. 2015 Apr;62(1S):S87-S99. doi: 10.1016/j.jhep.2015.02.006. Review.

6.

Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic HCV Genotype 1, 4, or 6 Infection: A Randomized Trial.

Zeuzem S, Ghalib R, Reddy KR, Pockros PJ, Ben Ari Z, Zhao Y, Brown DD, Wan S, DiNubile MJ, Nguyen BY, Robertson MN, Wahl J, Barr E, Butterton JR.

Ann Intern Med. 2015 Apr 24. doi: 10.7326/M15-0785. [Epub ahead of print]

PMID:
25909356
7.

Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis.

Gustot T, Fernandez J, Garcia E, Morando F, Caraceni P, Alessandria C, Laleman W, Trebicka J, Elkrief L, Hopf C, Solís-Munoz P, Saliba F, Zeuzem S, Albillos A, Benten D, Montero-Alvarez JL, Chivas MT, Concepción M, Córdoba J, McCormick A, Stauber R, Vogel W, de Gottardi A, Welzel TM, Domenicali M, Risso A, Wendon J, Deulofeu C, Angeli P, Durand F, Pavesi M, Gerbes A, Jalan R, Moreau R, Ginés P, Bernardi M, Arroyo V; CANONIC Study Investigators of the EASL-CLIF Consortium.

Hepatology. 2015 Apr 15. doi: 10.1002/hep.27849. [Epub ahead of print]

PMID:
25877702
8.

No Distal Migration in Unfixed Versus Fixed Cell Structure Covered Self-Expanding Metal Stents for Treatment of Benign Biliary Disease.

Walter D, Sarrazin C, Trojan J, Kronenberger B, Bojunga J, Zeuzem S, Friedrich-Rust M, Albert JG.

Dig Dis Sci. 2015 Apr 14. [Epub ahead of print]

PMID:
25868631
9.

[S3 guideline hepatitis C addendum].

Sarrazin C, Berg T, Buggisch P, Dollinger MM, Hinrichsen H, Hofer H, Hüppe D, Manns MP, Mauss S, Petersen J, Simon KG, van Thiel I, Wedemeyer H, Zeuzem S.

Z Gastroenterol. 2015 Apr;53(4):320-34. doi: 10.1055/s-0034-1399322. Epub 2015 Apr 13. German. No abstract available.

PMID:
25867048
10.

Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis.

Reddy KR, Bourlière M, Sulkowski M, Omata M, Zeuzem S, Feld JJ, Lawitz E, Marcellin P, Welzel TM, Hyland R, Ding X, Yang J, Knox S, Pang P, Dvory-Sobol H, Subramanian GM, Symonds W, McHutchison JG, Mangia A, Gane E, Mizokami M, Pol S, Afdhal N.

Hepatology. 2015 Apr 4. doi: 10.1002/hep.27826. [Epub ahead of print]

PMID:
25846144
12.

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders.

Fülöp B, Biermer M, Cornberg M, Wedemeyer H, Port K, Heyne R, Zeuzem S, Peiffer KH, Welzel T, Herber A, Buggisch P, Moser C, Stoll S, Alshuth U, Berg T.

Liver Int. 2015 Mar 19. doi: 10.1111/liv.12832. [Epub ahead of print]

PMID:
25801095
13.

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir.

Younossi ZM, Stepanova M, Afdhal N, Kowdley KV, Zeuzem S, Henry L, Hunt SL, Marcellin P.

J Hepatol. 2015 Mar 17. pii: S0168-8278(15)00192-0. doi: 10.1016/j.jhep.2015.03.014. [Epub ahead of print]

PMID:
25795586
14.

[Treatment of hepatitis C].

Schneider MD, Kronenberger B, Zeuzem S, Sarrazin C.

Internist (Berl). 2015 Apr;56(4):391-405. doi: 10.1007/s00108-015-3667-2. German.

PMID:
25762008
15.

Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis - authors' reply.

Dultz G, Piiper A, Zeuzem S, Kronenberger B, Waidmann O.

Aliment Pharmacol Ther. 2015 Apr;41(7):706. doi: 10.1111/apt.13110. No abstract available.

PMID:
25736154
16.

Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir.

Susser S, Flinders M, Reesink HW, Zeuzem S, Lawyer G, Ghys A, Van Eygen V, Witek J, De Meyer S, Sarrazin C.

Antimicrob Agents Chemother. 2015 May;59(5):2746-55. doi: 10.1128/AAC.04911-14. Epub 2015 Feb 23.

PMID:
25712364
17.

Daclatasvir and asunaprevir plus peginterferon alfa and ribavirin in HCV genotype 1 or 4 non-responders.

Jensen D, Sherman KE, Hézode C, Pol S, Zeuzem S, de Ledinghen V, Tran A, Elkhashab M, Younes ZH, Kugelmas M, Mauss S, Everson G, Luketic V, Vierling J, Serfaty L, Brunetto M, Heo J, Bernstein D, McPhee F, Hennicken D, Mendez P, Hughes E, Noviello S; HALLMARK-QUAD Study Team.

J Hepatol. 2015 Feb 19. pii: S0168-8278(15)00125-7. doi: 10.1016/j.jhep.2015.02.018. [Epub ahead of print]

PMID:
25703086
18.

Risk of infections during interferon-based treatment in patients with chronic hepatitis C virus infection and advanced hepatic fibrosis.

Maan R, van der Meer AJ, Hansen BE, Feld JJ, Wedemeyer H, Dufour JF, Lammert F, Manns MP, Zeuzem S, Janssen HL, de Knegt RJ, Veldt BJ.

J Gastroenterol Hepatol. 2015 Jun;30(6):1057-64. doi: 10.1111/jgh.12929.

PMID:
25682797
19.

Indication for 'Over the scope' (OTS)-clip vs. covered self-expanding metal stent (cSEMS) is unequal in upper gastrointestinal leakage: results from a retrospective head-to-head comparison.

Farnik H, Driller M, Kratt T, Schmidt C, Fähndrich M, Filmann N, Königsrainer A, Stallmach A, Heike M, Bechstein WO, Zeuzem S, Albert JG.

PLoS One. 2015 Jan 28;10(1):e0117483. doi: 10.1371/journal.pone.0117483. eCollection 2015.

20.

Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials.

Younossi ZM, Stepanova M, Marcellin P, Afdhal N, Kowdley KV, Zeuzem S, Hunt SL.

Hepatology. 2015 Jun;61(6):1798-808. doi: 10.1002/hep.27724. Epub 2015 Mar 18.

PMID:
25627448
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk